No Detail Found!

Hypomagnesaemia in Acute Exacerbation Chronic Obstructive Airway Disease; Association with Anthonisen's Levels of Exacerbation

Author(s)
Javaira Aziz Holy Family Hospital, Rawalpindi, Pakistan
Muhammad Amir Holy Family Hospital, Rawalpindi, Pakistan
Abrar Akbar Holy Family Hospital, Rawalpindi, Pakistan
Sadia Aziz National University of Medical Sciences, Rawalpindi, Pakistan
Nadia Shams Rawal Institute of Health Sciences, Rawalpindi, Pakistan
Lubna Meraj District Headquarter Hospital, Rawalpindi, Pakistan
Abstract
COPD claims significant morbidity and mortality all globally. Hypomagnesaemia has been observed in COPD patients with acute exacerbations. This study aims at identifying hypomagnesemia as a predictor of COPD exacerbations. This may minimize the exacerbations and hence the need for admission. Materials and Methods: The Descriptive cross-sectional study was conducted at DHQ Hospital Rawalpindi from 16 July 2016 to 15 Jan 2017 after the ethical approval and informed consent. The indoor adult (> 18 years) diagnosed cases of COPD exacerbation were included by consecutive sampling. Patients with malignancy, pregnancy, and receiving magnesium supplements were excluded. Demographic details were documented and after complete clinical evaluation, serum Magnesium levels were assessed. Serum Magnesium < 1.80 mg/dl labeled hypomagnesaemia. Data were analyzed by SPSS with a significant p< 0.05. Results: Amongst 176 patients; there were 93(52.8%) male patients and 83(47.2%) female COPD patients. The mean age was 56+7 years. The mean duration of COPD was 6.56 + 5.24 years (2-10 years). The mean height in the study was 181 +12 cm and the mean weight was 56.06 + 7.08 kg. The mean serum magnesium level was 1.5 + .49mg/dl. Low serum magnesium (<1.8 mg/dl) was observed in 103(58.5%), and gender wasn't associated with hypomagnesemia (p=0.294). Hypomagnesaemia in accordance to types of Anthonisen's criteria was observed in 19(44.2%) with Type I, 37(57.8%) with Type II, and 47(68.1%) with Type III COPD exacerbation. Hypomagnesaemia had a significant association with Anthinosen's levels of exacerbation (p=0.043). The mean age in patients with hypomagnesemia was 56.61+6.78 Vs. 55.30+7.47 in patients without hypomagnesemia (p=0.228). Conclusion: The study concludes that mean serum magnesium was significantly lower in acute exacerbation of COPD (58.5%), particularly in type II and III. The serum magnesium should be performed in all COPD exacerbations irrespective of gender and age. Replacement of magnesium may be helpful in alleviating symptoms and reducing the frequency of exacerbations.
Publication Details
Page(s) 195-201
Published Journal: Journal of Rawalpindi Medical College, Volume: 26, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
COPD, Serum Magnesium levels, Acute exacerbation, Hypomagnesaemia.
0

Citations

0

Downloads

43

Views